Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stylage HydroMax is an injectable dermal filler and skin booster developed by Laboratoires Vivacy. It contains cross-linked hyaluronic acid at a concentration of 12.5 mg/ml, combined with sorbitol, a moisturizing antioxidant. The product is indicated for treating severe skin dehydration, improving skin elasticity and firmness, and revitalizing the face, neck, décolleté, and hands. It is manufactured using the patented IPN-Like technology, which results in a monophasic gel that provides long-lasting hydration and stimulates the production of collagen and elastin. The inclusion of sorbitol helps maintain hydration and protects the hyaluronic acid from premature degradation, extending the results for typically 6 to 12 months.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Stylage HydroMax.